OPRX FINANCIAL STATEMENTS

OPTIMIZERx Corp — balance sheet, income statement and cash flow trends

OPRXOPTIMIZERx Corp

🇺🇸 USA · NASDAQ · Healthcare · Health Information Services

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue107.3 M $+13.8%

Gross Profit74.1 M $+22.5%

Operating Income14.6 M $—

EBITDA18.9 M $—

Net Income6.8 M $—

Peer Comparison· Health Information Services

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
OPRX	13.8%	69.0%	17.6%	6.4%
FONET	53.5%	39.8%	49.6%	26.0%
Industry median	7.1%	63.4%	12.4%	1.5%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
OPRX	13.8%	69.0%	17.6%	6.4%
HCAT	-2.8%	46.0%	-63.6%	-87.7%
AMWL	-9.3%	49.7%	-22.3%	-37.0%
DH	-3.9%	72.5%	4.9%	-71.5%
SPOK	-1.7%	87.1%	16.3%	9.3%
SLP	2.5%	62.0%	18.7%	-78.0%
Industry median	7.1%	63.4%	12.4%	1.5%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity129.6 M $77%
Current Liabilities10.5 M $6%
Long-term Liabilities27.2 M $16%

Key Figures

YoY change

Total Assets167.3 M $-0.3%

Total Liabilities37.7 M $-26.9%

Total Equity129.6 M $+11.5%

Cash & ST Investments20.2 M $+21.7%

Total Debt23.7 M $-27.7%

Net Debt3.5 M $-78.1%

Peer Comparison· Health Information Services

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
OPRX	5.37	18.3%	0.19	77.5%
FONET	2.31	2.5%	-0.21	90.9%
Industry median	1.83	22.0%	-0.01	64.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
OPRX	5.37	18.3%	0.19	77.5%
HCAT	1.69	123.5%	-0.32	33.5%
AMWL	3.09	1.7%	3.31	69.7%
DH	1.66	116.1%	-0.71	28.4%
SPOK	1.09	4.4%	-0.49	72.7%
SLP	5.47	0.4%	-2.74	91.3%
Industry median	1.83	22.0%	-0.01	64.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow14.4 M $+116.8%

Capital Expenditures52 K $-84.0%

Free Cash Flow14.3 M $+127.1%

Dividends Paid——

Peer Comparison· Health Information Services

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
OPRX	13.4%	13.4%	0.0%	210.4%
FONET	45.0%	9.6%	32.1%	173.0%
Industry median	17.1%	13.0%	1.6%	165.1%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
OPRX	13.4%	13.4%	0.0%	210.4%
HCAT	6.3%	3.0%	3.4%	-7.1%
AMWL	-17.6%	-17.6%	0.0%	47.6%
DH	16.5%	15.6%	7.4%	-23.1%
SPOK	21.3%	18.7%	2.6%	229.9%
SLP	30.3%	27.7%	2.5%	-38.8%
Industry median	17.1%	13.0%	1.6%	165.1%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on OPRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.